Literature DB >> 3722475

Experimental infection of pregnant sheep with Toxoplasma gondii: pathological and immunological observations on the placenta and foetus.

D Buxton, J Finlayson.   

Abstract

The pathogenesis of Toxoplasma gondii infection in pregnant sheep was investigated. In one experiment, sheep were infected at 40, 60 and 90 days gestation and examined 30 days later, while in a second experiment, pregnant sheep were infected at either 60 or 90 days gestation and examined 10, 15 and 20 days later. By 10 days post infection (dpi), the parasite had invaded the gravid uterus and caused focal damage in the caruncular septa and, by 15 days, the degenerative changes had spread to the crypt wall and trophoblast. At this time, toxoplasma were isolated from all challenged foetuses. Foetuses did not produce any significant immune response until 20 dpi when increased numbers of IgM positive cells were found in lymphoid tissues. However, at 30 dpi, the numbers were normal while numbers of IgG positive cells and circulating IgG were increased. It was concluded that, while the foetal immune system need not be fully mature to respond to T. gondii infection, its ability to mount a response is limited at 70 days gestation but becomes increasingly competent after this. Furthermore, while it is able to respond more comprehensively with increasing maturity, maturation itself appears to be accelerated by the stimulus of infection.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3722475     DOI: 10.1016/0021-9975(86)90052-6

Source DB:  PubMed          Journal:  J Comp Pathol        ISSN: 0021-9975            Impact factor:   1.311


  20 in total

Review 1.  Pathogens and the placental fortress.

Authors:  Jennifer R Robbins; Anna I Bakardjiev
Journal:  Curr Opin Microbiol       Date:  2011-12-12       Impact factor: 7.934

2.  Tissue barriers of the human placenta to infection with Toxoplasma gondii.

Authors:  Jennifer R Robbins; Varvara B Zeldovich; Anna Poukchanski; John C Boothroyd; Anna I Bakardjiev
Journal:  Infect Immun       Date:  2011-11-14       Impact factor: 3.441

3.  Detection of Neospora from tissues of experimentally infected rhesus macaques by PCR and specific DNA probe hybridization.

Authors:  M S Ho; B C Barr; A F Tarantal; L T Lai; A G Hendrickx; A E Marsh; K W Sverlow; A E Packham; P A Conrad
Journal:  J Clin Microbiol       Date:  1997-07       Impact factor: 5.948

4.  Investigation of Toxoplasma gondii and association with early pregnancy and abortion rates in New Zealand farmed red deer (Cervus elaphus).

Authors:  Kandarp Khodidas Patel; Elizabeth Burrows; Cord Heuer; Geoffrey William Asher; Peter Raymond Wilson; Laryssa Howe
Journal:  Parasitol Res       Date:  2019-06-11       Impact factor: 2.289

Review 5.  Microbial Vertical Transmission during Human Pregnancy.

Authors:  Nitin Arora; Yoel Sadovsky; Terence S Dermody; Carolyn B Coyne
Journal:  Cell Host Microbe       Date:  2017-05-10       Impact factor: 21.023

6.  Protective immunity against congenital toxoplasmosis with recombinant SAG1 protein in a guinea pig model.

Authors:  M Haumont; L Delhaye; L Garcia; M Jurado; P Mazzu; V Daminet; V Verlant; A Bollen; R Biemans; A Jacquet
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

Review 7.  Toxoplasma Effectors that Affect Pregnancy Outcome.

Authors:  David Arranz-Solís; Debanjan Mukhopadhyay; Jeroen J P Saeij
Journal:  Trends Parasitol       Date:  2020-11-21

Review 8.  Ovine toxoplasmosis: a review.

Authors:  D Buxton
Journal:  J R Soc Med       Date:  1990-08       Impact factor: 18.000

Review 9.  Animal models of intellectual disability: towards a translational approach.

Authors:  Carla A Scorza; Esper A Cavalheiro
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

10.  Comparative aspects of laboratory testing for the detection of Toxoplasma gondii and its differentiation from Neospora caninum as the etiologic agent of ovine abortion.

Authors:  Nicola Meixner; Marie F Sommer; Nelly Scuda; Kaspar Matiasek; Matthias Müller
Journal:  J Vet Diagn Invest       Date:  2020-10-07       Impact factor: 1.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.